Ilya Goldshleger, See remarks at RxSight, Inc. (RXST), sold 14,595 shares at $39.43 ($573K) on 2024-08-05, disclosed to the SEC on 2024-08-06.
Scheduled sale ($573k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.80 | 1,145 | $44K | 7.7% |
| 2 | $38.83 | 1,087 | $42K | 7.4% |
| 3 | $39.04 | 1,827 | $71K | 12.4% |
| 4 | $39.04 | 1,827 | $71K | 12.4% |
| 5 | $39.43 | 1,855 | $73K | 12.8% |
| 6 | $39.43 | 1,855 |
| $73K |
| 12.8% |
| 7 | $39.51 | 1,913 | $76K | 13.2% |
| 8 | $39.51 | 1,913 | $76K | 13.2% |
| 9 | $39.73 | 1,173 | $47K | 8.1% |
| Total | $39.28 avg | 14,595 | $573K | 100% |
| Filing → |
| RXST | SELL | 2024-11-26 | $282K | — | Filing → |
| RXST | SELL | 2024-11-18 | $364K | — | Filing → |
| RXST | SELL | 2024-11-14 | $123K | — | Filing → |